Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval crawled date : 2020 - 12 - 04 save search
PTC Announces Translarna™ Approval in Russia for the Treatment of Duchenne Muscular Dystrophy
Published: 2020-12-04 (Crawled : 16:00) - biospace.com/
PTCT | News S | $25.15 -1.02% 99K
|
Health Technology
|
| O: 0.94%
H: 1.93%
C: 1.48%
approval treatment duchenne
BioCryst Announces FDA Approval of ORLADEYO, First Therapy to Prevent HAE Attacks in Adults
Published: 2020-12-04 (Crawled : 14:00) - biospace.com/
BCRX | News | $4.27 -2.51% 1.6M
|
Health Technology
|
| O: 13.92%
H: 6.84%
C: 4.27%
therapy fda approval fda approval
BioCryst Announces FDA Approval of ORLADEYO, First Therapy to Prevent HAE Att...
Published: 2020-12-04 (Crawled : 14:00) - biospace.com/
BCRX | News | $4.27 -2.51% 1.6M
|
Health Technology
|
| O: 13.92%
H: 6.84%
C: 4.27%
therapy fda approval fda approval
BioCryst Announces FDA Approval of ORLADEYO™ (berotralstat), First Oral, Once-daily Therapy to Prevent Attacks in Hereditary Angioedema Patients
Published: 2020-12-04 (Crawled : 02:00) - globenewswire.com
BCRX | News | $4.27 -2.51% 1.6M
|
Health Technology
|
| O: 13.92%
H: 6.84%
C: 4.27%
therapy fda approval fda approval hereditary angioedema
Gainers vs Losers
| 54% | 46% |
Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M
|
Consumer Services
CZOO | $11.04 121.24% 9.6M
|
BOF | $2.05 75.21% 78M
|
AMST | $3.2 60.0% 63M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.05 44.75% 13M
|
Technology Services
TROO | $1.51 38.53% 5.6M
|
Manufacturing
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.